0001477932-18-006021.txt : 20181217
0001477932-18-006021.hdr.sgml : 20181217
20181217095109
ACCESSION NUMBER: 0001477932-18-006021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171108
FILED AS OF DATE: 20181217
DATE AS OF CHANGE: 20181217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Climate Change Investigation, Innovation & Investment Company, LLC
CENTRAL INDEX KEY: 0001759122
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55908
FILM NUMBER: 181237204
BUSINESS ADDRESS:
STREET 1: 12 SAN RAFAEL AVE
CITY: BELVEDERE
STATE: CA
ZIP: 94920
BUSINESS PHONE: 9252007127
MAIL ADDRESS:
STREET 1: 12 SAN RAFAEL AVE
CITY: BELVEDERE
STATE: CA
ZIP: 94920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp.
CENTRAL INDEX KEY: 0001643301
STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, FOIL & COATED PAPER BAGS [2673]
IRS NUMBER: 371765151
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
BUSINESS PHONE: 805-824-0410
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
FORMER COMPANY:
FORMER CONFORMED NAME: Makkanotti Group Corp.
DATE OF NAME CHANGE: 20150526
4
1
form4.xml
FORM 4
X0306
4
2017-11-08-07:00
false
0001643301
Cure Pharmaceutical Holding Corp.
CURR
0001759122
Climate Change Investigation, Innovation & Investment Company, LLC
12 SAN RAFAEL AVE
BELVEDERE
CA
94920
false
false
true
false
Common Stock
2018-07-07-06:00
4
M
false
297288
0.886
A
3495932
D
Warrant
7.00
2017-11-08-07:00
4
P
false
50000
250000
A
2017-11-08-07:00
2020-11-08-07:00
Common Stock
50000
50000
D
Warrant
1.00
2018-05-15-06:00
4
P
false
148644
250000
A
2018-05-15-06:00
2021-05-15-06:00
Common Stock
148644
198644
D
Conversion of Convertible Promissory Note.
The conversion price is the lesser of $7.00 or the price per share of the latest closing of a debt or equity offering by the Issuer greater than $3,000,000.
$250,000 is the principal amount paid for both a convertible note and the warrant on November 8, 2017.
Exercise price per share equal to the lower of (a) $1.00 or (b) 125% of the price of a qualified offering, and to purchase up to a number of shares of common stock equal to 50% of the number of shares of common stock issuable upon conversion of such purchaser's note.
The number of warrant shares are equal to fifty percent (50%) of the number of shares of common stock issued upon conversion of the note at the applicable conversion price under the note converted on 7/7/2018.
$250,000 is the principal amount paid for both a convertible note and the warrant on May 15, 2018.
/s/ James Farrell, Manager of Climate Change Investigation, Innovation and Investment Company, LLC
2018-12-13-07:00